Expression of vascular endothelial growth factors and their receptors in and around intracranial arteriovenous malformations

Neurosurgery

Volumn 50, Issue 1, 2002, Pages 117-124

  Koizumi, Toru ^a,d   Shiraishi, Tetsuya ^a   Hagihara, Naoshi ^a   Tabuchi, Kazuo ^a   Hayashi, Takashi ^b   Kawano, Teruaki ^c  

^a SAGA UNIVERSITY   (Japan)

^b ST MARY S HOSPITAL   (Japan)

^c Fukuoka Tokushukai Hospital   (Japan)

^d NONE   (Japan)

Author keywords

Arteriovenous malformation; Immunohistochemistry; Vascular endothelial growth factor (VEGF) family; VEGF receptor

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; ENDOTHELIAL CELL GROWTH FACTOR; GROWTH FACTOR RECEPTOR; LYMPHOKINE; PROTEIN TYROSINE KINASE;

ADOLESCENT; ADULT; AGED; ARTERIOVENOUS MALFORMATION; ARTICLE; BLOOD VESSEL WALL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MACROGLIA; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN ARTERY; ENZYME IMMUNOASSAY; FEMALE; MALE; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; CEREBRAL ARTERIES; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; LYMPHOKINES; MALE; MIDDLE AGED; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036371086     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200201000-00020     Document Type: Article

References (62)

1. Abdulrauf SI, Malik GM, Awad IA: Spontaneous angiographic obliteration of cerebral arteriovenous malformations. Neurosurgery 44:280-287, 1999.
2. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA: Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A 95:548-553, 1998.
3. Andre T, Kotelevets L, Vaillant JC, Coudray AM, Weber L, Prevot S, Parc R, Gespach C, Chastre E: VEGF, VEGF-B, VEGF-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa. Int J Cancer 86:174-181, 2000.
4. Bian XW, Du LL, Shi JQ, Cheng YS, Liu FX: Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas. Anal Quant Cytol Histol 22:267-274, 2000.
5. Breier G, Albrecht U, Sterrer S, Risau W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114:521-532, 1992.
6. Deckers MM, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, Lowik CW: Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141:1667-1674, 2000.
7. Dumont DJ, Yamaguchi TP, Conlon RA, Rossant J, Breitman ML: tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 7:1471-1480, 1992.
8. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18:4-25, 1997.
9. Folkman J: How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res 46:467-473, 1986.
10. Friese RE, Maciag T: Molecular mechanisms of angiogenesis: Fibroblast growth factor signal transduction. FASEB J 9:919-925, 1995.
11. Gabriel EM, Sampson JH, Wilkins RH: Recurrence of a cerebral arteriovenous malformation after surgical excision: Case report. J Neurosurg 84:879-882, 1996.
12. Hashimoto T, Emala CW, Joshi S, Mesa-Tejada R, Quick CM, Feng L, Libow A, Marchuk DA, Young WL: Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations. Neurosurgery 47:910-918, 2000.
13. Hatva E, Jääskeläinen J, Hirvonen H, Alitalo K, Haltia M: Tie endothelial cell-specific receptor tyrosine kinase is upregulated in the vasculature of arteriovenous malformations. J Neuropathol Exp Neurol 55:1124-1133, 1996.
14. Hayashi T, Abe K, Suzuki H, Itoyama Y: Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke 28:2039-2044, 1997.
15. Jakeman LB, Armanini M, Phillips HS, Ferrara N: Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 133:848-859, 1993.
16. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-1425, 1997.
17. Joukov V, Kaipainen A, Jeltsch M, Pajusola K, Olofsson B, Kumar V, Eriksson U, Alitalo K: Vascular endothelial growth factors VEGF-B and VEGF-C. J Cell Physiol 173:211-215, 1997.
18. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290-298, 1996.
19. Kader A, Goodrich JT, Sonstein WJ, Stein BM, Carmel PW, Michelsen WJ: Recurrent cerebral arteriovenous malformations after negative postoperative angiograms. J Neurosurg 85:14-18, 1996.
20. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841-844, 1993.
21. Kovacs Z, Ikezaki K, Samoto K, Inamura T, Fukui M: VEGF and flt: Expression time kinetics in rat brain infarct. Stroke 27:1865-1872, 1996.
22. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, Alitalo K: VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122:3829-3837, 1996.
23. Lauren J, Gunji Y, Alitalo K: Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am J Pathol 153:1333-1339, 1998.
24. Lawton MT, Hamilton MG, Spetzler RF: Multimodality treatment of deep arteriovenous malformations: Thalamus, basal ganglia, and brain stem. Neurosurgery 37:29-35, 1995.
25. Lawton MT, Jacobowitz R, Spetzler RF: Redefined role of angiogenesis in the pathogenesis of dural arteriovenous malformations. J Neurosurg 87:267-274, 1997.
26. Lennmyr F, Ata KA, Funa K, Olsson Y, Terent A: Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J Neuropathol Exp Neurol 57:874-882, 1998.
27. Levy DI, Kitz K, Killer M, Richling B: Radiosurgery in the treatment of cerebral AVMs. Acta Neurochir Suppl (Wien) 63:60-67, 1995.
28. Luo Z, Diaco M, Murohara T, Ferrara N, Isner JM, Symes JF: Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thorac Surg 64:993-998, 1997.
29. Malik G, Abdulrauf S, Yang XY, Gutierrez JA, Rempel SA: Expression of transforming growth factor-beta complex in arteriovenous malformations. Neurol Med Chir (Tokyo) 38[Suppl]:161-164, 1998.
30. Mayer PL, Kier EL: The ontogenetic and phylogenetic basis of cerebrovascular anomalies and variants, in Apuzzo MLJ (ed): Brain Surgery: Complication Avoidance and Management. New York, Churchill Livingstone, 1993, pp 691-792.
31. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A: High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846, 1993.
32. Mizoi K, Jokura H, Yoshimoto T, Takahashi A, Ezura M, Kinouchi H, Nagamine Y, Boku N: Multimodality treatment for large and critically located arteriovenous malformations. Neurol Med Chir (Tokyo) 38[Suppl]:186-192, 1998.
33. Mustonen T, Alitalo K: Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129:895-898, 1995.
34. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Nakano H, Matsumoto K, Nakamura T, Ogihara T: Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: Additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J Hypertens 14:1067-1072, 1996.
35. Nakamura Y, Morishita R, Nakamura S, Aoki M, Moriguchi A, Matsumoto K, Nakamura T, Higaki J, Ogihara T: A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension 28:409-413, 1996.
36. Nicosia RF, Nicosia SV, Smith M: Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 145:1023-1029, 1994.
37. Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S, Tanne K, Maeda N, Nishikawa S, Kodama H: Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 190:293-298, 1999.
38. Oehring RD, Miletic M, Valter MM, Pietsch T, Neumann J, Fimmers R, Schlegel U: Vascular endothelial growth factor (VEGF) in astrocytic gliomas: A prognostic factor? J Neurooncol 45:117-125, 1999.
39. Ogawa S, Oku A, Sawano A, Yamaguchi S, Yazaki Y, Shibuya M: A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J Biol Chem 273:31273-31282, 1998.
40. Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K, Eriksson U: Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A 93:2576-2581, 1996.
41. Orlandini M, Marconcini L, Ferruzzi R, Oliviero S: Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci U S A 93:11675-11680, 1996.
42. Padget DH: The development of the cranial arteries in the human embryo. Contrib Embryol 32:205-262, 1948.
43. Partanen J, Armstrong E, Makela TP, Korhonen J, Sandberg M, Renkonen R, Knuutila S, Huebner K, Alitalo K: A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 12:1698-1707, 1992.
44. Plate KH, Breier G, Millauer B, Ullrich A, Risau W: Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53:5822-5827, 1993.
45. Plate KH, Breier G, Risau W: Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 4:207-218, 1994.
46. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848, 1992.
47. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT: Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci U S A 90:7533-7537, 1993.
48. Rhoten RL, Comair YG, Shedid D, Chyatte D, Simonson MS: Specific repression of the preproendothelin-1 gene in intracranial arteriovenous malformations. J Neurosurg 86:101-108, 1997.
49. Risau W: Developing brain produces an angiogenesis factor. Proc Natl Acad Sci U S A 83:3855-3859, 1986.
50. Risau W: Mechanisms of angiogenesis. Nature 386:671-674, 1997.
51. Robinson JR Jr, Awad IA, Zhou P, Barna BP, Estes ML: Expression of basement membrane and endothelial cell adhesion molecules in vascular malformations of the brain: Preliminary observations and working hypothesis. Neurol Res 17:49-58, 1995.
52. Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M: Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ 7:213-221, 1996.
53. Shibuya M: Role of VEGF-flt receptor system in normal and tumor angiogenesis. Adv Cancer Res 67:281-316, 1995.
54. Shibuya M, Ito N, Claesson-Welsh L: Structure and function of vascular endothelial growth factor receptor-1 and -2. Curr Top Microbiol Immunol 237:59-83, 1999.
55. Sonstein WJ, Kader A, Michelsen WJ, Llena JF, Hirano A, Casper D: Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations: An immunocytochemical study. J Neurosurg 85:838-845, 1996.
56. Spetzler RF, Martin NA: A proposed grading system for arteriovenous malformations. J Neurosurg 65:476-483, 1986.
57. Takano S, Tsuboi K, Matsumura A, Tomono Y, Mitsui Y, Nose T: Expression of the angiogenic factor thymidine phosphorylase in human astrocytic tumors. J Cancer Res Clin Oncol 126:145-152, 2000.
58. Valavanis A, Yaşargil MG: The endovascular treatment of brain arteriovenous malformations. Adv Tech Stand Neurosurg 24:131-214, 1998.
59. Varlet P, Guillamo JS, Nataf F, Koziak M, Beuvon F, Daumas-Duport C: Vascular endothelial growth factor expression in oligodendrogliomas: A correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival. Neuropathol Appl Neurobiol 26:379-389, 2000.
60. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH: Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269:26988-26995, 1994.
61. Yaşargil MG: Pathological considerations, enlargement, growth, and regrowth of AVMs, in Microneurosurgery: AVM of the Brain, History, Embryology, Pathological Considerations, Hemodynamics, Diagnostic Studies, Microsurgical Anatomy. Stuttgart, Georg Thieme, 1987, vol 3A, pp 138-160.
62. Zagzag D: Angiogenic growth factors in neural embryogenesis and neoplasia. Am J Pathol 146:293-309, 1995.